Odyssey Therapeutics
BiotechnologyWebsite
Operator of a biotechnology company intended to develop immunomodulators and oncology drugs. The company aims to advance the drug discovery space with its product pipeline and accelerate the path of c...
Valuation
$0
Share Price
N/A
Total Raised
$716.2M
Last Round
Early Stage VC (Series B)
Oct 2022
Latest Funding Round
Early Stage VC (Series B)
Oct 13, 2022
$168M
raised
Investors
+32 other investors